Ballentine Partners, LLC Medtronic PLC Transaction History

Ballentine Partners, LLC

  • $5.81 Billion
  • Q4 2024

A detailed history of Ballentine Partners, LLC transactions in Medtronic PLC stock. As of the latest transaction made, Ballentine Partners, LLC holds 16,287 shares of MDT stock, worth $1.47 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
16,287
Previous 13,072 24.59%
Holding current value
$1.47 Million
Previous $1.18 Million 10.63%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
BUY
$79.61 - $92.24 $255,946 - $296,551
3,215 Added 24.59%
16,287 $1.3 Million
Q3 2024

Oct 23, 2024
SELL
$76.84 - $91.03 $113,953 - $134,997
-1,483 Reduced 10.19%
13,072 $1.18 Million
Q2 2024

Aug 06, 2024
BUY
$78.71 - $87.02 $61,866 - $68,397
786 Added 5.71%
14,555 $1.15 Million
Q1 2024

Apr 11, 2024
BUY
$82.84 - $88.09 $231,869 - $246,563
2,799 Added 25.52%
13,769 $1.2 Million
Q4 2023

Jan 23, 2024
SELL
$69.43 - $83.43 $243,352 - $292,422
-3,505 Reduced 24.21%
10,970 $903,000
Q3 2023

Oct 19, 2023
SELL
$78.22 - $90.4 $27,611 - $31,911
-353 Reduced 2.38%
14,475 $1.13 Million
Q2 2023

Jul 26, 2023
BUY
$79.47 - $91.38 $75,019 - $86,262
944 Added 6.8%
14,828 $1.31 Million
Q1 2023

Apr 27, 2023
BUY
$76.72 - $87.58 $437,534 - $499,468
5,703 Added 69.71%
13,884 $1.12 Million
Q4 2022

Jan 27, 2023
SELL
$76.18 - $87.74 $271,810 - $313,056
-3,568 Reduced 30.37%
8,181 $0
Q3 2022

Oct 26, 2022
BUY
$80.75 - $95.31 $117,249 - $138,390
1,452 Added 14.1%
11,749 $948,000
Q2 2022

Aug 09, 2022
SELL
$87.4 - $113.09 $231,697 - $299,801
-2,651 Reduced 20.47%
10,297 $925,000
Q1 2022

May 05, 2022
BUY
$100.58 - $112.38 $295,001 - $329,610
2,933 Added 29.29%
12,948 $1.44 Million
Q4 2021

Feb 14, 2022
BUY
$99.53 - $127.75 $122,820 - $157,643
1,234 Added 14.05%
10,015 $1.04 Million
Q3 2021

Oct 27, 2021
SELL
$122.75 - $135.17 $18,167 - $20,005
-148 Reduced 1.66%
8,781 $1.1 Million
Q2 2021

Aug 12, 2021
SELL
$118.19 - $131.5 $22,456 - $24,985
-190 Reduced 2.08%
8,929 $1.11 Million
Q1 2021

May 11, 2021
BUY
$111.18 - $119.74 $205,794 - $221,638
1,851 Added 25.47%
9,119 $1.08 Million
Q4 2020

Jan 25, 2021
SELL
$100.57 - $117.14 $40,630 - $47,324
-404 Reduced 5.27%
7,268 $850,000
Q3 2020

Oct 22, 2020
BUY
$90.13 - $108.78 $24,875 - $30,023
276 Added 3.73%
7,672 $798,000
Q2 2020

Jul 31, 2020
BUY
$84.11 - $103.33 $34,737 - $42,675
413 Added 5.91%
7,396 $678,000
Q1 2020

Apr 23, 2020
BUY
$72.92 - $121.3 $50,606 - $84,182
694 Added 11.04%
6,983 $629,000
Q4 2019

Jan 22, 2020
BUY
$104.49 - $114.54 $13,165 - $14,432
126 Added 2.04%
6,289 $714,000
Q3 2019

Oct 21, 2019
BUY
$98.02 - $111.18 $53,518 - $60,704
546 Added 9.72%
6,163 $670,000
Q2 2019

Jul 25, 2019
BUY
$84.15 - $99.38 $116,379 - $137,442
1,383 Added 32.66%
5,617 $547,000
Q1 2019

May 09, 2019
SELL
$82.45 - $93.79 $321,060 - $365,218
-3,894 Reduced 47.91%
4,234 $385,000
Q4 2018

Feb 04, 2019
BUY
$85.8 - $99.49 $335,735 - $389,304
3,913 Added 92.84%
8,128 $739,000
Q3 2018

Oct 30, 2018
SELL
$85.91 - $99.17 $11,683 - $13,487
-136 Reduced 3.13%
4,215 $414,000
Q2 2018

Jul 19, 2018
SELL
$77.48 - $87.83 $7,438 - $8,431
-96 Reduced 2.16%
4,351 $372,000
Q1 2018

Apr 26, 2018
SELL
$76.55 - $87.26 $22,811 - $26,003
-298 Reduced 6.28%
4,447 $356,000
Q4 2017

Feb 02, 2018
SELL
$76.93 - $83.5 $268,793 - $291,749
-3,494 Reduced 42.41%
4,745 $384,000
Q3 2017

Nov 06, 2017
BUY
$77.71 - $84.6 $640,252 - $697,019
8,239
8,239 $641,000

Others Institutions Holding MDT

# of Institutions
2,297
Shares Held
1.03B
Call Options Held
8.04M
Put Options Held
7.22M
View Full List

About Medtronic plc

MDT Quotes by TradingView
  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $120B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Ballentine Partners, LLC Portfolio

Follow Ballentine Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ballentine Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ballentine Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email